Silvia McColl Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
1,280
-20
-2% -$6.85K 0.28% 75
2026
Q1
$457K Sell
1,300
-34
-3% -$12.1K 0.3% 76
2025
Q4
$437K Sell
1,334
-135
-9% -$42.8K 0.29% 77
2025
Q3
$415K Sell
1,469
-65
-4% -$18.9K 0.28% 76
2025
Q2
$428K Sell
1,534
-9
-0.6% -$2.55K 0.31% 75
2025
Q1
$481K Sell
1,543
-144
-9% -$42.5K 0.36% 64
2024
Q4
$440K Sell
1,687
-193
-10% -$57.3K 0.33% 69
2024
Q3
$606K Sell
1,880
-1,765
-48% -$577K 0.45% 52
2024
Q2
$1.14M Sell
3,645
-7
-0.2% -$2.06K 0.94% 27
2024
Q1
$973K Buy
3,652
+423
+13% +$124K 0.83% 29
2023
Q4
$930K Buy
3,229
+545
+20% +$148K 0.84% 30
2023
Q3
$721K Sell
2,684
-1,211
-31% -$302K 0.72% 36
2023
Q2
$865K Hold
3,895
0.8% 32
2023
Q1
$942K Hold
3,895
0.93% 26
2022
Q4
$1.02M Buy
+3,895
New +$1.04M 1.01% 26

Other funds holding AMGN

Silvia McColl Wealth Management's AMGN Position: Q2 2026 in Review

Silvia McColl Wealth Management reduced its Amgen (AMGN) stake by 1.5% in Q2 2026, selling an estimated $6.85K and leaving 1,280 shares worth $464K. The position accounts for 0.28% of the portfolio, ranked #75.

Silvia McColl Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.14M in Q2 2024. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Silvia McColl Wealth Management held 1,280 shares of Amgen worth $464K as of Q2 2026.
  • Silvia McColl Wealth Management sold 20 Amgen shares in Q2 2026, an estimated $6.85K.
  • Amgen made up 0.28% of Silvia McColl Wealth Management's portfolio in Q2 2026, its #75 holding.
  • Silvia McColl Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Silvia McColl Wealth Management's Amgen position peaked at $1.14M in Q2 2024.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Silvia McColl Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.